The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Apolipoprotein E polymorphism and atherosclerosis.
Abstract
The apo E locus contributes to determining the variation in plasma cholesterol levels of healthy and diseased populations. It also influences the expression of hyperlipidemia and appears to modulate the susceptibility to atherosclerosis in a complex multifactorial interaction. There is evidence that the presence of apo E2 is protective, whereas that of apo E4 predisposes to coronary artery disease. The burden of proof, however, lies on future, well-designed clinical trials and prospective studies. The study of the biological significance of the apo E polymorphism in humans has emphasized the importance of gene-gene and gene-environment interactions in the pathogenesis of hyperlipidemia and atherosclerosis. The apo E polymorphism involves the coding region of the apo E gene and results in alterations of the gene product which, in turn, either directly or secondarily affect the metabolic fate of the lipoprotein particles. Rapid advances in knowledge over the last decade have provided a metabolic explanation for the observation of the opposite effects of the epsilon 4 and the epsilon 2 alleles on lipoprotein levels. Apo E2 has lower receptor binding affinity which results in delayed clearance of apo E2-bearing lipoprotein particles from plasma. Apo E4 is distributed differently from apo E3 between VLDL and HDL, is degraded more rapidly than apo E3, and may enhance the catabolism of E4-bearing particles, leading to other alterations in lipoprotein metabolism which result in elevated levels of LDL. In view of the significant opposite impacts of the epsilon 4 and the epsilon 2 alleles on plasma LDL cholesterol concentrations, it is evident that determination of the apo E phenotype will become a useful adjunct to the assessment of the cardiovascular risk profile of an individual. In addition, the relationship between the epsilon 2 allele and type III hyperlipoproteinemia provides a valuable model for the study of complex genetic interactions in the pathogenesis of hyperlipidemia. The further study of apo E and its interactions shows great promise for a deeper comprehension of the pathogenesis of atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The critical role of APOE in lipid metabolism is underscored by evidence showing that APOE2 homozygosity can lead to Hyperlipoproteinemia type III (HLP), characterized by mixed hypercholesterolemia and hypertriglyceridemia [35–39].”
In the citing paper
“This observation, coupled with evident mixed hypercholesterolemia and hypertriglyceridemia, supports the characterization of APOE2hAβ rats as a model for type III HLP”
In the citing paper
“Both the ε2 and the ε4 alleles are associated with unfavorable lipid profiles [8][9][10][11][12][13].”
From APOE and vascular disease: Sequencing and genotyping in general population cohorts (2023) · cites this paper as [13]
In the citing paper
“It is estimated that less than one in 20 individuals with the ε22 genotype will have overt type III hyperlipoproteinemia [24].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [24]
In the citing paper
“At the level of an individual the effect of the APOE polymorphism on plasma lipid levels is moderate, however since the APOE polymorphism is common, it contributes substantially to the total phenotypic variability in plasma lipid levels in the general population [21,24,58].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [24]
In the citing paper
“The pattern of associations between the six common APOE genotypes and plasma lipid levels is similar across populations, although the magnitude of the associations differs between populations and subgroups within populations; thus both context-dependent and invariant associations could be suggested [9,24,30].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [24]
In the citing paper
“Both ɛ2 and ɛ4 alleles are associated with unfavourable lipid profiles,12–19”
From Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort (2019) · cites this paper as [18]
In the citing paper
“a decreased risk of coronary artery disease (unless it is associated with type III hyperlipoproteinemia), 42,43”
From Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the ε4 Allele for Apolipoprotein E (1996) · cites this paper as [42]
Citations
Cites
Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W., & Taylor, J. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112130 · Cited by 829
Weisgraber, K. H., Rall, S. C., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52510-8 · Cited by 777
Lipoprotein receptors and cholesterol homeostasis
Mahley, R. W., & Innerarity, T. L. (1983) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(83)90001-1 · Cited by 756
Human apolipoprotein E. The complete amino acid sequence
Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34702-1 · Cited by 741
(1985) · PubMed · Cited by 706
Self-citationPolymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man
UTERMANN, G., HEES, M., & STEINMETZ, A. (1977) · Nature · doi:10.1038/269604a0 · Cited by 666
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Polymorphism of apolipoprotein E
Utermann, G., Vogelberg, K. H., Steinmetz, A., Schoenborn, W., Pruin, N., Jaeschke, M., Hees, M. T. I. W. S.-V., & Canzler, H. (1979) · Clinical Genetics · doi:10.1111/j.1399-0004.1979.tb02027.x · Cited by 408
Apolipoprotein E polymorphism in health and disease
Utermann, G. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90610-7 · Cited by 389
Elshourbagy, N. A., Liao, W. S., Mahley, R. W., & Taylor, J. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.203 · Cited by 376
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,005
Molecular interactions between apoE and ABCA1
Krimbou, L., Denis, M., Haidar, B., Carrier, M., Marcil, M., & Genest, J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300418-jlr200 · Cited by 116
Apolipoproteins and aging: emerging mechanisms
Smith, J. D. (2002) · Ageing Research Reviews · doi:10.1016/s1568-1637(02)00005-3 · Cited by 133
Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention
Mänttäri, M., Koskinen, P., Ehnholm, C., Huttunen, J. K., & Manninen, V. (1991) · Metabolism · doi:10.1016/0026-0495(91)90179-z · Cited by 131
Peacock, R. E., Hamsten, A., Nilsson‐Ehle, P., & Humphries, S. E. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90130-9 · Cited by 131
Reliability of reported family history of myocardial infarction.
Kee, F., Tiret, L., Robo, J. Y., Nicaud, V., McCrum, E. E., Evans, A., & Cambien, F. (1993) · BMJ · doi:10.1136/bmj.307.6918.1528 · Cited by 130
Corella, D., Tucker, K. L., Lahoz, C., Coltell, Ó., Cupples, L. A., Wilson, P. W. F., Schaefer, E. J., & Ordovás, J. M. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.4.736 · Cited by 130
Juottonen, K., Lehtovirta, M., Helisalmi, S., R., P. J., & Soininen, H. S. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.3.322 · Cited by 130
Lehtinen, S., Lehtimäki, T. J., Sisto, T., Salenius, J., Nikkilä, M. T., Jokela, H., Koivula, T. A., Ebeling, F. T., & Ehnholm, C. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05469-y · Cited by 129
Hegele, R. A., Brunt, J., & Connelly, P. W. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.1.89 · Cited by 129
Hanlon, C. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05402-5 · Cited by 129
Lipidomics as a Principal Tool for Advancing Biomedical Research
Lam, S. M., & Shui, G. (2013) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2013.06.007 · Cited by 131
GENETICS OF LIPOPROTEIN ABNORMALITIES ASSOCIATED WITH CORONARY HEART DISEASE SUSCEPTIBILITY
Breslow, J. L. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.233 · Cited by 128
Hemodynamic Consequences of Deformed Microvessels in the Brain in Alzheimer's Disease
de la Torre, J. C. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48462.x · Cited by 129
Harrington, C. R., Louwagie, J., Rossau, R., Vanmechelen, E., Perry, R. H., Perry, E. K., Xuereb, J. H., Roth, M., & Wischik, C. M. (1994) · PubMed Central · doi:10.25405/ncl.34087548 · Cited by 127
The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease
Amouyel, P., Vidal, O., Laplanche, J., & Launay, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90691-2 · Cited by 127
Frequency of the apolipoprotein E ε2 allele is diminished in sporadic Alzheimer disease
West, H. L., William Rebeck, G., & Hyman, B. T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)91074-x · Cited by 125
Rasmussen, K. L. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.037 · Cited by 125
Apolipoprotein E Genetic Variation and Alzheimer’s Disease
Rubinsztein, D. C., & Easton, D. F. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017120 · Cited by 151
ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation
Minihane, A. M., Jofre‐Monseny, L., Olano-Martin, E., & Rimbach, G. H. (2007) · Proceedings of The Nutrition Society · doi:10.1017/s0029665107005435 · Cited by 128
The Apolipoprotein E ε4 Allele and Outcome in Cerebrovascular Disease
McCarron, M. O., Muir, K. W., Weir, C. J., Dyker, A. G., Bone, I., Nicoll, J. A. R., & Lees, K. R. (1998) · Stroke · doi:10.1161/01.str.29.9.1882 · Cited by 125
ApoE isoform affects LTP in human targeted replacement mice
Trommer, B. L., Shah, C., Yun, S. H., Gamkrelidze, G., Pasternak, E. S., Ye, G. L., Sotak, M., Sullivan, P. M., Pasternak, J. F., & LaDu, M. J. (2004) · NeuroReport · doi:10.1097/00001756-200412030-00020 · Cited by 124
Critical threshold cerebral hypoperfusion causes Alzheimer's disease?
de la Torre, J. C. (1999) · Acta Neuropathologica · doi:10.1007/s004010051044 · Cited by 124
del Castillo, F. J., Rodríguez-Ballesteros, M., Martín, Y., Arellano, B., Gallo-Terán, J., Morales‐Angulo, C., Ramírez-Camacho, R., Tapia, M. C., Solanellas, J., Martínez-Conde, A., et al. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.8.632 · Cited by 123
Impaired chylomicron remnant clearance in familial combined hyperlipidemia.
Cabezas, M. C., de Bruin, T. W. A., Jansen, H., Kock, L. A., Kortlandt, W., & Erkelens, D. W. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.804 · Cited by 123
Russo, G. T., Meigs, J. B., Cupples, L. A., Demissie, S., Otvos, J. D., Wilson, P. W. F., Lahoz, C., Cucinotta, D., Couture, P., Mallory, T., et al. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00409-9 · Cited by 125
Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM
Cummings, M. H., Watts, G. F., Umpleby, A. M., Hennessy, T. R., Naoumova, R. P., Slavin, B. M., Thompson, G. R., & S�nksen, P. H. (1995) · Diabetologia · doi:10.1007/bf00400586 · Cited by 121
Circulating Biomarkers of Cognitive Decline and Dementia
Solfrizzi, V., D'Introno, A., Colacicco, A. M., Capurso, C., Todarello, O., Pellicani, V., Capurso, S. A., Pietrarossa, G., Santamato, V., Capurso, A., et al. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.015 · Cited by 120
Increased caveolin-1 expression in Alzheimer’s disease brain
Gaudreault, S. B., Dea, D., & Poirier, J. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.07.004 · Cited by 120
Corder, E. H., Lannfelt, L., Viitanen, M. H., Corder, L. S., Manton, K., Winblad, B. G., & Basun, H. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550050048022 · Cited by 120
Cholesterol paradox: Is high total or low HDL cholesterol level a risk for Alzheimer's disease?
Michikawa, M. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10585 · Cited by 124
Dietary Fatty Acids, Lipoproteins, and Cardiovascular Disease
McNamara, D. J. (1992) · Advances in food and nutrition research · doi:10.1016/s1043-4526(08)60107-2 · Cited by 122
Kaprio, J., Ferrell, R. E., Kottke, B. A., Kamboh, M. I., & Sing, C. F. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1330 · Cited by 119
Self-citationThe relationship between blood pressure and dementia: a review
Skoog, I. G. (1997) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(97)89428-0 · Cited by 119
Gylling, H., & Miettinen, T. A. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40550-4 · Cited by 119
APO E gene and gene-environment effects on plasma lipoprotein-lipid levels
HAGBERG, J. M., WILUND, K. R., & FERRELL, R. E. (2000) · Physiological Genomics · doi:10.1152/physiolgenomics.2000.4.2.101 · Cited by 118
Kotze, M. J., de Villiers, W. J. S., Steyn, K., Kriek, J. A., Marais, A. D., Langenhoven, E., Herbert, J. S., van Roggen, J. F. G., van der Westhuyzen, D. R., & Coetzee, G. A. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.10.1460 · Cited by 118
The vascular contribution to Alzheimer's disease
Altman, R., & Rutledge, J. C. (2010) · Clinical Science · doi:10.1042/cs20100094 · Cited by 93
Zhao, Y., Miao, H., Cheng, X., & Wei, F. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.09.005 · Cited by 120
Evidence of RPGRIP1 gene mutations associated with recessive cone-rod dystrophy
Hameed, A. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.8.616 · Cited by 117
Carmena, R., Roederer, G. O., Mailloux, H., Lussier‐Cacan, S., & Davignon, J. (1993) · Metabolism · doi:10.1016/0026-0495(93)90066-w · Cited by 117
Self-citationImpaired Olfaction Predicts Cognitive Decline in Nondemented Older Adults
Swan, G. E., & Carmelli, D. (2002) · Neuroepidemiology · doi:10.1159/000048618 · Cited by 116
Genetic Basis of Variation in Carotid Artery Wall Thickness
Duggirala, R., Villalpando, C. G., O’Leary, D. H., D, M. P. S. M., & Blangero, J. (1996) · Stroke · doi:10.1161/01.str.27.5.833 · Cited by 116
Association Between Apolipoprotein E Alleles and Calcific Valvular Heart Disease
Novaro, G. M., Sachar, R., Pearce, G. L., Sprecher, D. L., & Griffin, B. P. (2003) · Circulation · doi:10.1161/01.cir.0000097560.96431.3e · Cited by 116
Kuusisto, J., Mykkänen, L. M., Kervinen, K., Kesäniemi, Y. A., & Laakso, M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1280 · Cited by 116
Apo E allele frequencies in younger (age 42–50) vs older (age 65–90) women
Cauley, J. A., Eichner, J. E., Ilyas Kamboh, M., Ferrell, R. E., & Kuller, L. H. (1993) · Genetic Epidemiology · doi:10.1002/gepi.1370100104 · Cited by 115
Triglycerides: a risk factor for coronary heart disease
Davignon, J., & Cohn, J. S. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05858-3 · Cited by 116
Self-citationGene-diet interaction in determining plasma lipid response to dietary intervention
Ordovás, J. M., López‐Miranda, J., Mata, P., Pérez‐Jiménez, F., Lichtenstein, A. H., & Schaefer, E. J. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)90069-1 · Cited by 115
Cullen, P., Cignarella, A., Brennhausen, B., Mohr, S., Assmann, G., & von Eckardstein, A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119887 · Cited by 114
Cattin, L., Fisicaro, M., Tonizzo, M., Valenti, M., Danek, G. M., Fonda, M., Col, P. G. D., Casagrande, S., Pincetti, E., Bovenzi, M., et al. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.1.91 · Cited by 114
Reduced levels of human apoE4 protein in an animal model of cognitive impairment
Sullivan, P. M., Han, B., Liu, F., Mace, B. E., Ervin, J. F., Wu, S., Koger, D., Paul, S., & Bales, K. R. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.05.011 · Cited by 113
Heffernan, A. L., Chidgey, C., Peng, P., Masters, C. L., & Roberts, B. R. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0804-x · Cited by 113
Bangen, K. J., Beiser, A., Delano‐Wood, L., Nation, D. A., Lamar, M., Libon, D. J., Bondi, M. W., Seshadri, S. S., Wolf, P. A., & Au, R. (2013) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2013.03.013 · Cited by 115
DeCarli, C. S., Reed, T., Miller, B. L., Wolf, P. A., Swan, G. E., & Carmelli, D. (1999) · Stroke · doi:10.1161/01.str.30.8.1548 · Cited by 114
The hemochromatosis gene affects the age of onset of sporadic Alzheimer’s disease
Sampietro, M., Caputo, L., Casatta, A., Meregalli, M., Pellagatti, A., Tagliabue, J., Annoni, G., & Vergani, C. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00219-6 · Cited by 111
Wang, X. L., McCredie, R. M., & Wilcken, D. E. L. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.8.1030 · Cited by 110
Apolipoprotein E Polymorphism and Stroke in a Population Sample Aged 75 Years or More
Basun, H., Corder, E. H., Guo, Z., Lannfelt, L., Corder, L. S., Manton, K., Winblad, B. G., & Viitanen, M. H. (1996) · Stroke · doi:10.1161/01.str.27.8.1310 · Cited by 110
Fatty acids, lipid metabolism and Alzheimer pathology
Hooijmans, C. R., & Kiliaan, A. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.081 · Cited by 115
Sarkkinen, E. S., Korhonen, M. J., Erkkilä, A. T., Ebeling, T., & Uusitupa, M. I. J. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.6.1215 · Cited by 109
The Role of Lipids and Lipoproteins in Atherosclerosis
Linton, M. F., Yancey, P. G., Davies, S. S., Jerome, W. G., Linton, E. F., Song, W., Doran, A. C., & Vickers, K. C. (2015) · Europe PMC (PubMed Central) · Cited by 108
Tsukamoto, K., Tangirala, R. K., Chun, S. H., Puré, E., & Rader, D. J. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.9.2162 · Cited by 110
APOE ε4 does not predict mortality, cognitive decline, or dementia in the oldest old
Juva, K., Verkkoniemi, A., Viramo, P., Polvikoski, T., Kainulainen, K., Kontula, K., & Sulkava, R. (2000) · Neurology · doi:10.1212/wnl.54.2.412 · Cited by 108
Humphries, S. E., Ye, S., Talmud, P. J., Bara, L., Wilhelmsen, L., & Tiret, L. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.1.96 · Cited by 108
Gene Polymorphisms Predicting High Plasma Levels of Coagulation and Fibrinolysis Proteins
Mannucci, P. M., Mari, D., Merati, G., Peyvandi, F., Tagliabue, L., Sacchi, E., Taioli, E., Sansoni, P., Bertolini, S., & Franceschi, C. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.4.755 · Cited by 106
McKay, G. J., Silvestri, G., Chakravarthy, U., Dasari, S., Fritsche, L. G., Weber, B. H., Keilhauer, C. N., Klein, M. L., Francis, P. J., Klaver, C. C., et al. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr015 · Cited by 105
APOE Genotype and Alzheimer’s Disease: The Influence of Lifestyle and Environmental Factors
Angelopoulou, E., Paudel, Y. N., Papageorgiou, S. G., & Piperi, C. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00295 · Cited by 109
Apolipoprotein E: Implications for AD neurobiology, epidemiology and risk assessment
Schipper, H. M. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.021 · Cited by 113
Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.
Kamboh, M. I. (1995) · PubMed · Cited by 105
Weisgraber, K. H., & Shinto, L. H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99060-5 · Cited by 104
Kamboh, M. I. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05409-c · Cited by 104
Genetic Architecture of Common Multifactorial Diseases
Sing, C. F., Haviland, M. B., & Reilly, S. L. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514887.ch12 · Cited by 104
Self-citationKokubo, Y., Chowdhury, A. H., Date, C., Yokoyama, A., Sobue, H., & Tanaka, H. (2000) · Stroke · doi:10.1161/01.str.31.6.1299 · Cited by 103
Ghebranious, N. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni155 · Cited by 103
Choi, Y. H., Kim, J.-H., Kim, D. K., Kim, J.-W., Kim, D., Lee, M. S., Kim, C. H., & Park, S. C. (2003) · The Journals of Gerontology Series A · doi:10.1093/gerona/58.3.m227 · Cited by 103
Wang, J. M., Irwin, R. W., & Brinton, R. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608128103 · Cited by 104
Kamboh, M. I., Ferrell, R. E., & Kottke, B. A. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38431-5 · Cited by 103
Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis.
de Andrade, M., Thandi, I., Brown, S., Gotto, A. M., Patsch, W., & Boerwinkle, E. (1995) · PubMed Central · Cited by 103
The Blood–Brain Barrier in Alzheimer's Disease
Sharma, H. S., Castellani, R. J., Smith, M. A., & Sharma, A. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00003-x · Cited by 105
Apolipoprotein E4allele in the normal elderly: neuropsychologic and brain MRI correlates
Schmidt, H., Schmidt, R., Fazekas, F., Semmler, J., Kapeller, P., Reinhart, B., & Kostner, G. M. (1996) · Clinical Genetics · doi:10.1111/j.1399-0004.1996.tb02377.x · Cited by 104
Apolipoprotein E Polymorphism and Silent Microangiopathy-Related Cerebral Damage
Schmidt, R., Schmidt, H., Fazekas, F., Schumacher, M., Niederkorn, K., Kapeller, P., Weinrauch, V., & Kostner, G. M. (1997) · Stroke · doi:10.1161/01.str.28.5.951 · Cited by 101
Association of Apo E Polymorphism With Plasma Lipid Levels in a Multiethnic Elderly Population
Pablos-Méndez, A., Mayeux, R. P., Ngai, C. I., Shea, S., & Berglund, L. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.12.3534 · Cited by 102
Association of the APOE epsilon 4 allele with disease activity in multiple sclerosis
Evangelou, N., Jackson, M. T., Beeson, D., & Palace, J. A. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.2.203 · Cited by 101
Alzheimer's disease: How does it start?
de la Torre, J. C. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4606 · Cited by 102
Togo, T., Cookson, N., & Dickson, D. W. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00421.x · Cited by 100
Genetics strongly determines the wall thickness of the left and right carotid arteries
Zannad, F. M., Visvikis‐Siest, S., Gueguen, R., Sass, C., Chapet, O., Herbeth, B., & Siest, G. (1998) · Human Genetics · doi:10.1007/s004390050804 · Cited by 100
Apolipoprotein E Isoform Phenotype and LDL Subclass Response to a Reduced-Fat Diet
Dreon, D. M., Fernstrom, H. A., Miller, B., & Krauss, R. M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.1.105 · Cited by 100
Apolipoprotein E and Atherosclerosis
Davignon, J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000154570.50696.2c · Cited by 100
Self-citationSalt bridge relay triggers defective LDL receptor binding by a mutant apolipoprotein.
Wilson, C., Mau, T., Weisgraber, K. H., Wardell, M. R., Mahley, R. W., & Agard, D. A. (1994) · Structure · doi:10.1016/s0969-2126(00)00072-1 · Cited by 100
Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B-100 in men.
Millar, J. S., Lichtenstein, A. H., Cuchel, M., Dolnikowski, G. G., Hachey, D. L., Cohn, J. S., & Schaefer, E. J. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41124-1 · Cited by 98
Bergeron, N., & Havel, R. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118408 · Cited by 100
Arbonés-Mainar, J. M., Johnson, L. A., Altenburg, M. K., & Maeda, N. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.143 · Cited by 99
Orchard, T. J., Eichner, J. E., Kuller, L. H., Becker, D. J., McCallum, L. M., & Grandits, G. A. (1994) · Annals of Epidemiology · doi:10.1016/1047-2797(94)90041-8 · Cited by 97
Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice
Hamanaka, H. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.3.353 · Cited by 99
Saupe, J., Shearer, M. J., & Kohlmeier, M. (1993) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/58.2.204 · Cited by 96
Biobehavioral characteristics of nondemented older adults with subclinical brain atrophy
Swan, G. E., DeCarli, C. S., Miller, B. L., Reed, T., Wolf, P. A., & Carmelli, D. (2000) · Neurology · doi:10.1212/wnl.54.11.2108 · Cited by 96
Humphries, S. E., Ridker, P. M., & Talmud, P. J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000116216.56511.39 · Cited by 96
Familial Hypercholesterolemia in the Finnish North Karelia
Vuorio, A. F., Turtola, H., Piilahti, K.-M., Repo, P. E., Kanninen, T., & KONTULA, K. K. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.3127 · Cited by 96
Cohn, J. S., Tremblay, M., Amiot, M., Bouthillier, D., Roy, M., Genest, J. J., & Davignon, J. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.1.149 · Cited by 96
Self-citationNieminen, M. S., Mattila, K. J., Aalto‐Setälä, K., Kuusi, T., Kontula, K., Kauppinen-Mäkelin, R., Ehnholm, C., Jauhiainen, M., Valle, M., & Taskinen, M. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.1.58 · Cited by 96
ApoE genotype: from geographic distribution to function and responsiveness to dietary factors
Egert, S., Rimbach, G. H., & Huebbe, P. (2012) · Proceedings of The Nutrition Society · doi:10.1017/s0029665112000249 · Cited by 97
Relation of Coronary Atherosclerosis and Apolipoprotein E Genotypes in Alzheimer Patients
Kosunen, O., Talasniemi, S., Lehtovirta, M., Heinonen, O., Helisalmi, S., Mannermaa, A., Paljärvi, L., Ryynänen, M., Riekkinen, P. J., & Soininen, H. (1995) · Stroke · doi:10.1161/01.str.26.5.743 · Cited by 95
Metadata
- Authors
- Davignon, J., Gregg, R. E., & Sing, C. F.
- Affiliations
- Montreal Clinical Research Institute (CA)
- Venue
- Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Published
- 1988-01
- Volume
- 8
- Issue
- 1
- Pages
- 1-21
- ISSN
- 0276-5047 (ISSN-L)
- OpenAlex
- W2066644955
- Cited by
- 1,981
- References
- 98
- Citations by year
- 2026: 10 · 2025: 7 · 2024: 17 · 2023: 10 · 2022: 9 · 2021: 21 · 2020: 21 · 2019: 21 · 2018: 27 · 2017: 28 · 2016: 23 · 2015: 33 · 2014: 31 · 2013: 40 · 2012: 49
- FWCI
- 83.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis An Official Journal of the American Heart Association Inc (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL24489, HL-39107)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- APOE polymorphism, atherosclerosis, coronary artery disease, hyperlipidemia, LDL cholesterol, lipoprotein metabolism, gene-environment interaction, type III hyperlipoproteinemia, cardiovascular risk assessment, genetic susceptibility
- MeSH terms
- Alleles, Apolipoproteins, Apolipoproteins E, Arteriosclerosis, Coronary Disease, Humans, Lipids, Lipoproteins, Phenotype, Polymorphism, Genetic, Radiography, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
